Eli Lilly is investing up to $4 billion in the Bristol project and Wisconsin plans to provide up to $100 million in ...

You'll get access to an ad-free website with a faster photo browser, the chance to claim free tickets to a host of events ...

The Wisconsin Economic Development Corp. is offering pharmaceutical giant Eli Lilly up to $100 million in tax credits to ...

Eli Lilly is eligible for 100M in tax credits to expand its Pleasant Prairie facility, adding 750 jobs and boosting Wisconsin ...

Pharmaceutical giant Eli Lilly and Company is receiving up to $100 million in performance-based state tax credits, Wisconsin ...

Key Points Eli Lilly's biggest growth driver, tirzepatide, will continue facing scrutiny from investors and analysts. The company's oral GLP-1 candidate will soon report key phase 3 results in ...

Business Insider spoke to Eli Lilly's new president of cardiometabolic health, who shared the company's aggressive incretin drug strategy.

Pharmaceutical giant Eli Lilly delivers strong financial results and has a deep lineup and pipeline. Much smaller Viking Therapeutics boasts several candidates whose progress could jolt its shares.

Eli Lilly outpaces Novo in the GLP-1 market with Tirzepatide and emerging blockbusters, signaling future growth. Read more on my Strong Buy rating for LLY.

The Kenosha County Sheriff's Office is searching for a 22-year-old man with autism who was last seen between 6:45 and 7:45 a.m. Wednesday.